SCHEMBL13049687

SCHEMBL13049687

O=C(O)c1cccc(-c2oc3ccccc3c2CO)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMO O15229 1/20 0.47
▸ PTPN1 P18031 2/20 0.46
▸ ACP1 P24666 1/20 0.46
▸ TTR P02766 2/20 0.46
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ MAPT P10636 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ GAA P10253 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ KDM4E B2RXH2 4/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ MAP2K4 P45985 1/20 0.43
▸ MAPKAPK3 Q16644 1/20 0.43
▸ MAPK6 Q16659 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13049770 0.83 TNKS (0.51) MEN1KMT2AALDH1A1MAPTGAA
SCHEMBL2962849 0.82 KMT2A (0.53) PTPN1MEN1KMT2AALDH1A1MAPT
SCHEMBL13049691 0.80 MEN1 (0.43) PTPN1ACP1MEN1KMT2AALDH1A1
SCHEMBL13049693 0.79 MAPT (0.48) MEN1KMT2AALDH1A1MAPTLMNA
SCHEMBL13049690 0.79 MEN1 (0.60) MEN1KMT2AALDH1A1MAPTLMNA
SCHEMBL13049762 0.78 MEN1 (0.43) PTPN1ACP1MEN1KMT2AALDH1A1
SCHEMBL13211169 0.78 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTLMNA
SCHEMBL13049766 0.76 MAPT (0.49) MEN1KMT2AALDH1A1MAPTGAA
SCHEMBL19846946 0.74 KMT2A (0.64) PTPN1ACP1MEN1KMT2AALDH1A1
SCHEMBL8442687 0.72 CYP2C19 (0.50) KMOPTPN1TTRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7837981-B2 Methods for imaging soluble A-beta GENERAL ELECTRIC COMPANY (US) 2010-11-23 — — US disclosed
US-7837981-B2 Methods for imaging soluble A-beta GENERAL ELECTRIC COMPANY (US) 2010-11-23 — — US disclosed
EP-1631561-B1 COMPOSITIONS AND METHODS FOR NON-INVASIVE IMAGING OF SOLUBLE BETA-AMYLOID GEN ELECTRIC (US) 2010-08-18 — — EP disclosed
US-7727511-B2 Agents for imaging soluble a-beta GENERAL ELECTRIC COMPANY (US) 2010-06-01 — — US disclosed
US-7727511-B2 Agents for imaging soluble a-beta GENERAL ELECTRIC COMPANY (US) 2010-06-01 — — US disclosed
US-20070189967-A1 AGENTS FOR IMAGING SOLUBLE A-BETA GENERAL ELECTRIC COMPANY (US) 2007-08-16 — — US disclosed
US-20070189967-A1 AGENTS FOR IMAGING SOLUBLE A-BETA GENERAL ELECTRIC COMPANY (US) 2007-08-16 — — US disclosed
US-20070140960-A1 METHODS FOR IMAGING SOLUBLE A-BETA GENERAL ELECTRIC COMPANY (US) 2007-06-21 — — US disclosed
US-20070140960-A1 METHODS FOR IMAGING SOLUBLE A-BETA GENERAL ELECTRIC COMPANY (US) 2007-06-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070140960-A1 METHODS FOR IMAGING SOLUBLE A-BETA APBA1, APP, FABP7 KMO 4385/4885PTPN1 4473/4885ACP1 563/4885
US-20070189967-A1 AGENTS FOR IMAGING SOLUBLE A-BETA APBA1, APP, FABP7 KMO 4658/4885PTPN1 4345/4885ACP1 389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback